Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor In Vitro and In Vivo

Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor In Vitro and In Vivo

Curcumin (Cur) exhibits biological activities that support its candidacy for cancer treatment. However, there are limitations to its pharmacological effects, such as poor solubility and bioavailability. Notably, the use of Cur analogs has potential for addressing these limitations. Dehydrozingerone...

Full description

Bibliographic Details
Main Authors: Sariya Mapoung, Shugo Suzuki, Satoshi Fuji, Aya Naiki-Ito, Hiroyuki Kato, Supachai Yodkeeree, Natee Sakorn, Chitchamai Ovatlarnporn, Satoru Takahashi, Pornngarm Limtrakul (Dejkriengkraikul)
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Molecules
Subjects:
curcumin analogs
dehydrozingerone
prostate cancer
pharmacokinetic
anticancer
Online Access:https://www.mdpi.com/1420-3049/25/12/2737

Internet

https://www.mdpi.com/1420-3049/25/12/2737

Similar Items